China NMPA Inspection - Suzhou Qingxin Health Technology Co., Ltd. - October 13, 2020
Discuss this record with AI
This document, published on October 13, 2020, by the National Medical Products Administration (NMPA), serves as an official notification regarding an unannounced inspection of Suzhou Qingxin Health Technology Co., Ltd. The document's primary purpose is to announce the inspection event itself, not to detail the findings, violations, or required corrective actions. Therefore, specific inspection dates, a list of main violations or issues identified, the precise regulatory framework invoked beyond the NMPA's general oversight, and any mandated actions for the company are not included within this notification. The information provided is limited to the company name and the fact that an unannounced inspection was initiated by the NMPA.
- Product Type
- Drugs
ID · 91dc0493-ba9a-4109-bd05-024bfc23d1aa